251 related articles for article (PubMed ID: 37312133)
21. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
[TBL] [Abstract][Full Text] [Related]
22. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons.
Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM
J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761
[TBL] [Abstract][Full Text] [Related]
23. Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.
Sorrentino ZA; Hass E; Vijayaraghavan N; Gorion KM; Riffe CJ; Dhillon JS; Giasson BI
Neurosci Lett; 2020 Jul; 732():135017. PubMed ID: 32371157
[TBL] [Abstract][Full Text] [Related]
24. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.
Liu CW; Giasson BI; Lewis KA; Lee VM; Demartino GN; Thomas PJ
J Biol Chem; 2005 Jun; 280(24):22670-8. PubMed ID: 15840579
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.
Diepenbroek M; Casadei N; Esmer H; Saido TC; Takano J; Kahle PJ; Nixon RA; Rao MV; Melki R; Pieri L; Helling S; Marcus K; Krueger R; Masliah E; Riess O; Nuber S
Hum Mol Genet; 2014 Aug; 23(15):3975-89. PubMed ID: 24619358
[TBL] [Abstract][Full Text] [Related]
26. α-synuclein buildup is alleviated via ESCRT-dependent endosomal degradation brought about by p38MAPK inhibition in cells expressing p25α.
Borland H; Rasmussen I; Bjerregaard-Andersen K; Rasmussen M; Olsen A; Vilhardt F
J Biol Chem; 2022 Nov; 298(11):102531. PubMed ID: 36162505
[TBL] [Abstract][Full Text] [Related]
27. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.
Graves NJ; Gambin Y; Sierecki E
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510
[TBL] [Abstract][Full Text] [Related]
28. The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.
Underwood R; Wang B; Carico C; Whitaker RH; Placzek WJ; Yacoubian TA
J Biol Chem; 2020 Jun; 295(23):8005-8016. PubMed ID: 32350025
[TBL] [Abstract][Full Text] [Related]
29. Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson's disease.
Girard V; Jollivet F; Knittelfelder O; Celle M; Arsac JN; Chatelain G; Van den Brink DM; Baron T; Shevchenko A; Kühnlein RP; Davoust N; Mollereau B
PLoS Genet; 2021 Nov; 17(11):e1009921. PubMed ID: 34788284
[TBL] [Abstract][Full Text] [Related]
30. Sortilin acts as an endocytic receptor for α-synuclein fibril.
Ishiyama S; Hasegawa T; Sugeno N; Kobayashi J; Yoshida S; Miki Y; Wakabayashi K; Fukuda M; Kawata Y; Nakamura T; Sato K; Ezura M; Kikuchi A; Takeda A; Aoki M
FASEB J; 2023 Jul; 37(7):e23017. PubMed ID: 37272890
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.
Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J
Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620
[TBL] [Abstract][Full Text] [Related]
33. Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala.
Chen L; Nagaraja C; Daniels S; Fisk ZA; Dvorak R; Meyerdirk L; Steiner JA; Escobar Galvis ML; Henderson MX; Rousseaux MWC; Brundin P; Chu HY
Elife; 2022 Jul; 11():. PubMed ID: 35775627
[TBL] [Abstract][Full Text] [Related]
34. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway.
Park JH; Burgess JD; Faroqi AH; DeMeo NN; Fiesel FC; Springer W; Delenclos M; McLean PJ
Mol Neurodegener; 2020 Jan; 15(1):5. PubMed ID: 31931835
[TBL] [Abstract][Full Text] [Related]
35. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
[TBL] [Abstract][Full Text] [Related]
36. Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms.
Röntgen A; Toprakcioglu Z; Tomkins JE; Vendruscolo M
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2313465121. PubMed ID: 38324572
[TBL] [Abstract][Full Text] [Related]
37. Lipids as
Ikenaka K; Suzuki M; Mochizuki H; Nagai Y
Front Neurosci; 2019; 13():693. PubMed ID: 31333408
[TBL] [Abstract][Full Text] [Related]
38. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
[TBL] [Abstract][Full Text] [Related]
39. Sex and Age Differences in a Progressive Synucleinopathy Mouse Model.
Lamontagne-Proulx J; Coulombe K; Morissette M; Rieux M; Calon F; Di Paolo T; Soulet D
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371557
[TBL] [Abstract][Full Text] [Related]
40. alpha-Synucleinopathy models and human neuropathology: similarities and differences.
Kahle PJ
Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]